<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-E6I8WUEO</identifier><date>2018</date><creator>Janež, Andrej</creator><creator>Janić, Miodrag</creator><creator>Lunder, Mojca</creator><creator>Šabovič, Mišo</creator><relation>documents/doc/E/URN_NBN_SI_doc-E6I8WUEO_001.pdf</relation><relation>documents/doc/E/URN_NBN_SI_doc-E6I8WUEO_001.txt</relation><format format_type="volume">87</format><format format_type="issue">9/10</format><format format_type="type">article</format><format format_type="extent">str. 493-505</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID_HOST">34020825</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-E6I8WUEO</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="eng">blood pressure</subject><subject language_type_id="eng">glycaemia control</subject><subject language_type_id="slv">krvni tlak</subject><subject language_type_id="eng">SGLT-2 inhibitors</subject><subject language_type_id="slv">SGLT-2 zaviralci</subject><subject language_type_id="slv">urejenost glikemije</subject><title>a novelty in the treatment of type 2 diabetes</title><title>novost v zdravljenju sladkorne bolezni tipa 2</title><title>SGLT-2 inhibitors</title><title>Zaviralci SGLT-2</title></Record>